Rutgers: Why Cell Therapy Cancer Treatment Sometimes Fails
April 30, 2026
April 30, 2026
NEW BRUNSWICK, New Jersey, April 30 (TNSjou) -- Rutgers University issued the following news:
* * *
Why Cell Therapy Cancer Treatment Sometimes Fails
By Andrew Smith
Chimeric Antigen Receptor (CAR) T-cell therapy is one of oncology's most powerful ideas: Harvest a cancer patient's own immune cells, genetically engineer them to recognize tumor cells, multiply them in a laboratory and reinject them as a living drug.
For so . . .
* * *
Why Cell Therapy Cancer Treatment Sometimes Fails
By Andrew Smith
Chimeric Antigen Receptor (CAR) T-cell therapy is one of oncology's most powerful ideas: Harvest a cancer patient's own immune cells, genetically engineer them to recognize tumor cells, multiply them in a laboratory and reinject them as a living drug.
For so . . .